A survey of radiation dose to patients and medical staff during different diagnostic procedures using TLD dosimetry Kiki Theodorou, PhD Assistant Professor on Medical Physics Medical Physics Department Medical School, University of Thessaly Aims of the study 1. 2. 3. 4. TLD calibration for dose measurement of low energy x-rays Dose measurement for different radiological procedures Determination of local Dose Reference Levels (DRLs) for those procedures Risk assessment for patients, staff and accompanying persons Dose monitoring in Diagnostic Radiology Calculation of organ’s effective dose Risk calculation Determination of Dose Reference Levels (DRLs) Dose optimization to patients and staff Is the law! Means of Patient Dosimetry in Diagnostic Radiology Direct methods: TLDs, Films, MOSFETs, and Diodes Indirect methods: DAP, Monte Carlo Simulations, Mathematical (experimental) formulae Material TLD - LiF Small size – Easy placement Tissue equivalence Dose rate & angular dependence Dose & Energy Dependence No temperature & pressure correction needed Dose response 20 Saturation dose 15 Relative TL-light output 10 Up to 1 Gy for “LiF” ~ 1000 Gy for “LiF” Superlinear region 5 Linear region 0 1 10 100 Dose [Gy] 1000 Energy response Relative response TLD Dose Calculation D = (R-B) * C * kE* kF * kD R – TLD reader output signal B – Background signal C – TLD system calibration factor kE – energy correction factor kD – dose response correction factor kF – correction factor for fading TLD Calibration Procedure Photon energies between 50 – 110 kV Individual calibration for each radiation machine Calibration for entrance dose v.s. calibrated ion-chamber Determination of calibration factor according to the procedure for each TLD used TLD Calibration Procedure Effective Dose & Risk Estimation E Wt.Ht NRPB-SR279 ICRP 103 Radiological Procedures Micturating Cystourethrography (MCU) Hysterosalpingography (HSG) Angiography Lower limbs Renal arteries Carotid arteries More procedures have been measured… Micturating Cystourethrography (MCU) The MCU is considered to be the gold standard method used to detect and grade vesicoureteric reflux Represents the 30-50% of all fluoroscopic examinations in children. Children have a risk probability 2 to 3 times more than that of all adults of 50 years age Patient and Co-patient Dosimetry TLDs were placed in a thin plastic foil Each one contains 4 TLDs. TLD placed on : Patient Skin at the ESD, testes, Ovaries and Thyroid At the left shoulder level of the Co-patient Organ dose estimation 52 patients included in this study Organ dose estimated using computer software (CHILDOSE) provided by the NRPB-SR279). The doses are also normalised to unit ESD (mGy) and unit DAP (Gy.cm2). Thyroid Ovaries Ovaries Center Field Testicle MCU Results (mGy) Patient criteria All patients Positive Negative ESD mean±SD (range) Thyroid mean±SD (range) Testes/ovaries mean±SD (range) co-patient mean±SD (range) 52 1.134±0.56 (0.372-2.36) 0.153±0.101 (0.021-0.53) 0.364±0.39 (0.052-1.78) 0.144±0.09 (0.034-0.5) 11 1.49±0.54 (0.954-2.04) 0.184±0.15 (0.044-0.348) 0.638±0.53 (0.113-1.162) 0.11± 0.09 (0.0350.221) 41 1.08±0.57 (0.372-2.363) 0.144±0.10 (0.021-0.534) 0.49±0.40 (0.052-1.78) 0.149±0.10 (0.034-0.5) n DRL = 1.7mGy MCU Results Risk estimation and the probability of fatal cancer and hereditary effects are 107 people per mSv. Organ Effective dose (mSv) Risk of malignancy* 107/Sv Genetic effect 107/Sv Thyroid 0.008 0.0064 - Ovaries 0.084 0.84 8.4 Testes 0.073 0.73 7.3 MCU Results Mean ESD (mGy) per examination in various studies. Age group Author Newborn Present study 1.15±0.5 Chapple et al 1 year old - 2 year old 1.05±0.5 >5 years old - 7.63 - 11.56 Fotakis et al 3.49 4.49 - 5.76 Mantovani & Giroletti - 2.21 - 5.82 Hysterosalpingography (HSG) 37 women – Mean age 34 years old Fluoroscopy and radiography Tyroid 5 points of ESD measurement (4TLDs/pack) Center Field Staff dose measurement Central line Symphysis pubisiliac spine Central line Symphysis pubisiliac spine Symphysis Pubis HSG Results Entrance Dose - ESD (mGy) Group No Min Median Mean DRL Max Thyroid ESD Mean (range) Total 37 0,7 3,40 3,60 4,94 8,17 0,17 (0,06-0,51) 0,18 (0,04-0,46) A 23 0,7 3,16 3,30 3,40 6,98 0,19 (0,06-0,51) 0,21 (0,05-0,46) B 14 1,11 4,01 3,90 5,48 8,17 0,14 (0,06-0,14) 0,14 (0,04-0,25) Staff Dose HSG Results HSG Results Organs Eq. Dose (mSv) Probability Carcinogenesis x10-6 Ovaries 0,91 1,46 Uterus 1,28 0,81 Bone marrow 0,14 0,31 Bladder 1,22 4,76 Breast 0,04 0,46 Thyroid 0,03 0,06 HSG Results Authors No pat Fruoro Time (second) No radiographs ESD (mGy) Ovaries Dose (mGy) Eff. Dose (mSv) This Study 37 18,2 (6-36) 0,2 (0-1) 3,60 (0,7-8,17) 0,91 0,43 Perisinakis et al. 78 20 3,2 9,7±4,2 2,7 1,2 Calicchia et al. 37 13 (6-30) 6.5 (6-7) 25,2±3,8 4,66 1,95 Gregan et al. 21 15 (5-45) 2 (2-4) 14,6 (1,4-45,7) 3,4 Khouri et al. 25 - 4-15 12,6 (4,99-36,6) 2,94 - - Angiographies Dynamic Procedures Lower limbs Renal arteries Carotid arteries Angiographies Staff doses ΕEff = 0,02 mSv /examination Eye Lens Thyroid Lung Dose (μSv) Lower Limbs Renal Arteries Angioo Angio 14,9 14,1 0,75 0,7 1,7 Carotid Arteries 15 0,75 1,8 Angiographies 6 areas of measurement 4 areas of measurement 10 areas of measurement Angiography of Renal Arteries Lower Limbs Angiography Angiography of Carotid Arteries (30 patients) (21 patients) (27 patients) Angiography of lower limbs Results ESD (mGy) Abdomen Pelvis Thigh Knees Heels Mean ESD/image 70,8 21,1-207,4 96,0 67,7 13,5-188,5 96,4 24,3 5,8-40,7 32,7 18,4 3,4-59,0 23,1 9,7 0,3-31,7 12,3 2,1 Author Time (sec) No images Author Eff. Dose (mSv) This Study 96 103,7 This Stdy 9,8 Bor et al. 60 - D Bor et al. 2,8-10,95 Bor et al. 60-282 59-165 Castellano IA et al. 3,1 McParland et al. 432 450 - Hoskins PR et al. 2,8-9 B J McParland et al. 8,3 Mini et al. 144 114 H. M. Olerud et al. 6,4 Ruiz Cruce et al.. 222 37 R Ruiz Cruces et al. 6,2 Struelens et al. - 28-98 L. Struelens et al. 3,9-16,8 Thwaites et al. 145 29,9 J H Thwaites et al. 4 Wall et al. 126 - J. Zoetelief et al. 7,2 Angiography of renal arteries Results Author Fluoro Time (min) No radiographic images Sample This Study 1,5 71,5 21 Bor et al. 3,0 - 5,2 28-190 6 Mini et al. 2,8 88 17 McParland 5,1 - 6 Goni et al. 3,9 - 63 Livingstone et al. 2,42-9,79 196-303 109 Padovani 6,3 - - Angiography of renal arteries Results Eff. Dose (mSv) Mean Range Median Std Dev DRL 15,9 5,3-32,6 16,3 8,2 22,3 Authos Eff. Dose (mSv) This Study 15,9 D Bor et al. 8,95-13,7 B J McParland 6,4 H. M. Olerud et al 11,9 Mini et al. 25 R S Livingstone et al 2,3 - 30,5 G J Kemerink 2,3-7,1 Angiography of carotid arteries Results Fluoro Time (min) No radiographic Images Sample This Study 11 155,5 27 Bor et al. 5 83 19 Bor et al. 2,3-16,6 36-831 35 Mini et al. 7,8 199 12 McParland 10,3 - 11 Goni et al. 6,1 - 19 Bor et al. 3,3 122,6 5 1,1-3,4 - 17 11,3 - 35 Author Struelens et al. Fletcher Angiography of carotid arteries Results Mean Range Median Std. Dev. DRL 8,9 0,9-21,9 7,0 6,3 13,88 Eff. Dose (mSv) Authors Eff. Dose (mSv) This Study 8,9 D Bor et al. 2,5-4,9 Bor et al. 4,28-18,75 B J McParland 4,9 Olerud H M et al. 9,77 D Bor et al. 11,1 Conclusions Formation of a consistent dosimetric protocol for TLD dose measurement in diagnostic radiology Determination of DRLs in ALL radiological procedures is necessary for better radiation protection Optimization of static and dynamic radiological procedures based on absorbed dose to different sensitive organs Dose optimization to medical staff present to interventional examinations THANK YOU .